Glycostem will present on the virtual Berenberg Conference USA 2021 on 18^th May, 2021, to share the latest updates of our company and products, and host one-on-one meetings with investors.

Glycostem to present at virtual event Stability V: Challenges of in-use stability demonstration hosted by Joint Pharmaceutical Analysis Group, to talk about in use stability considerations for large molecules.  

Glycostem to participate the Oppenheimer 31st Annual Healthcare Conference, a virtual investor event, on Wednesday, March 17, 2021. Our CEO Troels Jordansen will provide an overview of the company and progress. Glycostem will host one-on-one meetings with investors during the event.

Glycostem will present on the virtual 10th Annual Global Healthcare Conference hosted by SVB Leerink on 23^rd Feb, 2021, to share the latest updates of our company and products, and host one-on-one meetings with investors.

Glycostem to participate the CAR-TCR Digital Summit Europe during 16^th to 18^th Feb, 2021, with workshop with our CSO Jan Spanholtz: viveNK™ products (CAR-NK and TCR-NK) as autologous CAR-T alternatives and conference presentation by our CDO Volker Huppert: clinical scale closed manufacture system for allogeneic NK products on.

Glycostem to participate on BIO CEO & Investor Digital Conference during 16th to 18th Feb, 2021, one of the biggest biotech industry networking events in the U.S.